Skip to main
COR

Cencora Inc (COR) Stock Forecast & Price Target

Cencora Inc (COR) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 54%
Hold 15%
Sell 0%
Strong Sell 0%

Bulls say

Cencora is a leading player in the pharmaceutical wholesale industry, with a strong presence in the domestic market and a recent expansion into the European market. The company's diversified portfolio includes distribution services, commercialization services, specialty drug logistics, and animal health product distribution. Its differentiated strategy of vertical integration, particularly in its leading retina MSO platform, provides insulation from industry risks and positions the company for future growth. However, potential regulatory changes, cybersecurity threats, and customer concentration are key risks that could negatively impact the company's distribution margins and fee structures.

Bears say

Cencora is facing intensifying scrutiny from regulatory bodies, including the FTC, due to their dominant market position and recent acquisitions. The company may face challenges in securing approval for future acquisitions, and the potential for increased regulation in the pharmaceutical industry could impact their profitability and revenue. Cencora's customer concentration and contract renewal risk also pose potential threats to their revenue and earnings. Overall, these challenges could potentially hinder the company's growth and profitability, leading to a negative outlook for their stock.

Cencora Inc (COR) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 54% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cencora Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cencora Inc (COR) Forecast

Analysts have given Cencora Inc (COR) a Buy based on their latest research and market trends.

According to 13 analysts, Cencora Inc (COR) has a Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $368.46, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $368.46, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cencora Inc (COR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.